Deleting Degs1 from adult mice either prevented or reversed hepatic steatosis in ob/ob mice by blunting lipid uptake (via the fatty acid translocase CD36) and decreasing expression of lipogenic genes (e.g., Srebf1). The gene discussed is DEGS1; the disease is Hepatic steatosis.